Research Article
Correlation of CK5 and EGFR with Clinicopathological Profile of
Triple-Negative Breast Cancer
Table 1
Clinicopathological variables.
| Clinicopathological variables |
| Age (years) | Mean | 45.18 |
| Tumor size (cm) | ≤2 cm | 13 | 2–5 cm | 18 | >5 cm | 5 |
| Histopathological diagnosis | IDC, NOS | 29 | Mucinous carcinoma | 2 | Metaplastic carcinoma | 1 | Medullary carcinoma | 3 | Mixed ductal-lobular carcinoma | 1 |
| Tumor necrosis | Present | 16 | Absent | 20 |
| Margin | Infiltrative | 25 | Pushing margin | 11 |
| Lymphocytic infiltrate | Present | 23 | Absent | 13 |
| Tumor grade | Grade I | 5 | Grade II | 17 | Grade III | 14 |
| Lymph node metasatases | Absent | 12 | 1 to 3 | 14 | >4 | 10 |
| Tumour stage | Stage I | 5 | Stage II | 16 | Stage III | 13 | Stage IV | 2 |
| Ki-67 | Positive | 29 | Negative | 7 |
| Immunohistochemical panel | CK5+ EGFR+ | 22 | CK5+ EGFR− | 5 | CK5− EGFR+ | 9 | CK5− EGFR− | Nil |
|
|